FDA Inspection 905793 — Central Pennsylvania Blood Bank

Central Pennsylvania Blood Bank — FEI 1000161167

The FDA completed an inspection of Central Pennsylvania Blood Bank on December 4, 2014 in Ephrata, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 4, 2014
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Ephrata, PA (United States)